Devin Cohen joined Ropes & Gray’s corporate department in 2015 as an associate in its health care group, and has a wide range of experience in transactional and regulatory matters affecting clients across the health care industry, including academic medical centers, insurers, for-profit and non-profit hospitals and health care systems, ambulatory surgery centers, post-acute providers, physician groups, and physician practice management organizations. His transactional practice focuses on strategic affiliations, mergers and acquisitions, complex provider alignment, and vertical integration models. Devin provides regulatory counsel to clients seeking guidance on value-based health care, state and federal insurance and risk-bearing provider organization requirements, data privacy and security, tax-exempt models, and compliance with federal and state fraud and abuse laws.
Prior to joining the firm, Devin was an associate in the health industry advisory practice group at a prominent Boston law firm. Devin is actively involved in community service, and has fundraised for over 29 children’s hospitals nationwide and advised hospital leadership regarding on-going collaborative relationships with Fortune 500 companies and surrounding communities. He also maintains a pro bono practice focused on non-profit incorporation and oversight, and was named a 2013 AHLA pro bono champion.
- Regularly advises physician practice management organizations, health systems, hospitals, and physician group practices on expansion opportunities, structural considerations, and care coordination standards.
- Negotiates and advises clients on wide range of physician group practice acquisitions, vertical integration opportunities, and strategic insurer transactions.
- Develops and negotiates provider-based and independent management services joint ventures with non-profit and for-profit hospitals, health maintenance organization networks, and specialty physician groups.
- Advises non-profit, university teaching hospitals on joint and collaborative clinical research program expansion opportunities.
- Assisted with negotiating and drafting complex clinical affiliation agreements between a client health system and nationally-renowned cancer hospital, and another client health system and regional urgent care center network.
- Advises private equity firms on strategic investments for health care targets, including pharmacies, DME manufacturers, independent clinical research sites, and clinical research organizations.
- Drafts transactional documents, manages diligence teams, and oversees closings for client mergers and acquisitions of hospitals, health systems, ambulatory surgery centers, and DMEPOS suppliers.
- Advised prominent health care system on federal and state grant procurement considerations in connection with acquisition of a research-focused medical school.
- Advises Medicare Advantage organizations, hospitals, physician groups, and preferred vendors on value-based health care structuring opportunities in commercial and government markets, and providers on payer contract negotiation strategies.
- Coordinated for-profit hospital system’s bundled payment and cost initiative (BPCI) contracting and rollout plan, and continues to advise for profit and non-profit care partners on BPCI Advanced and CMS Direct Contracting participation and contracting standards.
- Advises insurance plans on product offering requirements to conform with state and federal risk-sharing, reserve, and consumer protection requirements.
- Advised D-SNP plan sponsor compliance department on CMS program rules and Medicare Marketing Guideline requirements.
- Advises providers, insurers, pharmaceutical and medical device manufacturers, and other industry stakeholders on Federal Anti-Kickback, Stark Law, and False Claims Act compensation, sales, investment, and expansion structuring options and requirements.
- Advises medical device and pharmaceutical manufacturers on regulatory standards related to customer and patient interactions, marketing and clinician education standards, industry and jointly sponsored CME, patient assistance programs, and related compliance program requirements.
- Advises pharmaceutical, medical device companies, universities, and clinical research organizations on sponsored, investigator initiated, and collaborative clinical trial research regulatory requirements and contracting issues.
- Acted as one of Massachusetts’ largest physician groups’ physician contracting and fraud and abuse advisor, and regularly advises physician groups regarding related government investigations.
- Advised clients on compliance with c. 224 of Massachusetts health reform and state pharmaceutical marketing laws.
- Co-author, “What’s New For CMS Bundled Payments Program,” Law360 (June 3, 2019)
- Co-author, “BPCI Advanced: Key considerations for prospective model participants,” Milliman Inc. White Paper (April 9, 2019)
- Co-author, “Global HIV/AIDS Prevention and Treatment: Public Health Ethics Considerations,” The Oxford Handbook of Public Health Ethics (February 2019)
- Co-author, “New CMS Rules Reinforce Trend Away From Traditional Care,” Law360 (November 29, 2018)
- Co-author, "How Conduct Abroad Impacts Health Care Business In US," Law360 (October 12, 2017)
- Contributor, “Drafting Privacy Policies,” legal guide by Bureau of National Affairs (January, 2015)
- Author, “Health Law Case Brief: Paula Tartarini vs. Department of Mental Retardation,” Health Law Case Brief, Boston Bar Association Health Law Reporter (Fall/Winter, 2012)
- Speaker, “BPCI Advanced: Key Considerations for Current and Prospective Model Participants,” Ropes & Gray Webinar (June 13, 2019)
- JD, cum laude, Harvard Law School, 2012; Program of Study Fellow & Student Fellow, Petrie-Flom Health Law Center
- BA (History, Religious Studies), magna cum laude, Brown University, 2009
Admissions / Qualifications
- Massachusetts, 2012